RT Book, Section
A1 Lee, Charlotte
A1 Dec,  G. William
A2 Fuster, Valentin
A2 Narula, Jagat
A2 Vaishnava, Prashant
A2 Leon, Martin B.
A2 Callans, David J.
A2 Rumsfeld, John S.
A2 Poppas, Athena
SR Print(0)
ID 1202454909
T1 Obstructive and Nonobstructive Coronary Disease in Heart Failure
T2 Fuster and Hurst's The Heart, 15e
YR 2022
FD 2022
PB McGraw-Hill Education
PP New York, NY
SN 9781264257560
LK accesscardiology.mhmedical.com/content.aspx?aid=1202454909
RD 2024/04/20
AB Content  UpdateStudy  Summary:  REVIVED-BCIS2The  Revascularization  for  Ischemic  Ventricular  Dysfunction  (REVIVED-BCIS2)  trial  was  a  prospective,  multicenter,  open-label  trial  that  randomized  700  patients  with  left  ventricular  dysfunction  (defined  as  left  ventricular  ejection  fraction  (LVEF)  of  ≤35%),  extensive  coronary  artery  disease  amenable  to  percutaneous  coronary  intervention  (PCI),  and  demonstrable  myocardial  viability  to  a  strategy  of  optimal  medical  therapy  (OMT)  plus  PCI  (n=347)  or  OMT  alone  (n  =  353).  Read  More